China-Japan Union Hospital of Jilin University Reports Findings in Alzheimer Dis ease (EBF1 is a potential biomarker for predicting progression from mild cogniti ve impairment to Alzheimer’s disease: an in silico study)
China-Japan Union Hospital of Jilin University Reports Findings in Alzheimer Dis ease (EBF1 is a potential biomarker for predicting progression from mild cogniti ve impairment to Alzheimer’s disease: an in silico study)
扫码查看
点击上方二维码区域，可以放大扫码查看
Abstract
By a News Reporter-Staff News Editor at Robotics & Machine Learning Daily News Daily News – New research on Neurodegenerative Dise ases and Conditions - Alzheimer Disease is the subject of a report. According to news reporting originating in Changchun, People’s Republic of China, by NewsRx journalists, research stated, “The prediction of progression from mild cognitive impairment (MCI) to Alzheimer’s disease (AD) is an important clinical challenge . This study aimed to identify the independent risk factors and develop a nomogr am model that can predict progression from MCI to AD.” Financial support for this research came from Department of Science and Technolo gy of Jilin Province.
Key words
Changchun/People’s Republic of China/A sia/Alzheimer Disease/Biomarkers/Brain Diseases and Conditions/Central Nervo us System Diseases and Conditions/Cyborgs/Dementia/Diagnostics and Screening/Emerging Technologies/Genetics/Health and Medicine/Machine Learning/Neurode generative Diseases and Conditions/Risk and Prevention/Tauopathies
NETL
NSTL